New GB MRLs for ametoctradin amending the GB MRL Statutory Register

The United Kingdom would like to advise Members of an error in notificationG/SPS/N/GBR/118, ‘New GB MRLs for ametodactrin amending the GB MRL Statutory Register’. This corrigendum amends an error in the original notification. The active substance was misspelt in the title of the notified document in Section 5. The correct spelling is ametoctradin. To clarify, the corrected title should read: ‘New GB MRLs for ametoctradin amending the GB MRL Statutory Register’.There has been no change to the notified measure, and the document remains available via the link provided in the original notification.  The final date for adoption and publication on this notification remains unchanged.